Cue Health Inc. HLTH
We take great care to ensure that the data presented and summarized in this overview for Cue Health Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HLTH
View all-
Tarsadia Capital, LLC New York, NY10.7MShares$747,9356.24% of portfolio
-
Oakmont Corp9.6MShares$671,6740.45% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC8.98MShares$628,6632.19% of portfolio
-
Decheng Capital LLC Menlo Park, CA8.98MShares$628,6630.23% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA7.08MShares$495,4990.18% of portfolio
-
Jabodon Pt CO Reno, NV3.98MShares$278,6880.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$271,8990.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.13MShares$218,7500.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.85MShares$199,5380.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$109,3350.0% of portfolio
Latest Institutional Activity in HLTH
Top Purchases
Top Sells
About HLTH
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Insider Transactions at HLTH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2024
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,456
-0.46%
|
$0
$0.19 P/Share
|
|
Mar 05
2024
|
Christopher K Achar Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,482
-0.52%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Randall E. Pollard Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,304
-1.43%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,742
-0.09%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,604
-0.29%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Aasim Javed Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,327
-1.3%
|
$0
$0.25 P/Share
|
|
Feb 16
2024
|
Rishi Reddy Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,300
+46.59%
|
-
|
|
Feb 08
2024
|
Christopher K Achar Director |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+15.58%
|
-
|
|
Feb 08
2024
|
Randall E. Pollard Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+28.15%
|
-
|
|
Feb 08
2024
|
Ayub K Khattak President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
700,000
+5.28%
|
-
|
|
Feb 08
2024
|
Clint Sever Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+10.18%
|
-
|
|
Feb 08
2024
|
Aasim Javed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+21.93%
|
-
|
|
Dec 26
2023
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,781
-0.65%
|
$0
$0.3 P/Share
|
|
Dec 26
2023
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,938
-0.27%
|
$0
$0.3 P/Share
|
|
Dec 05
2023
|
Erica Palsis General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-0.76%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Randall E. Pollard Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,186
-1.95%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,885
-0.4%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Christopher K Achar Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,465
-0.56%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,722
-0.12%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Aasim Javed Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,623
-2.31%
|
$0
$0.35 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.66M shares |
|---|
| Payment of exercise price or tax liability | 602K shares |
|---|